Tag: biotechnolgy
Rubius reports $39.4M loss in Q2, heralds progress
PROVIDENCE – Rubius Therapeutics Inc. reported on Tuesday a loss of $39.4 million in the second quarter of 2019, or 50 cents per diluted...
TOPICS
PBN's All Access Subscription
PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.
PBN's Daily Newsletters
Get PBN's top stories and breaking news every day in your email inbox.
Helping you succeed in business since 1986.
© Providence Business News. All Rights Reserved.